Cargando…
C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage
Temozolomide (TMZ) is the standard of care chemotherapeutic agent used in the treatment of glioblastoma multiforme. Cytotoxic O6-methylguaine lesions formed by TMZ are repaired by O6-methyl-guanine DNA methyltransferase (MGMT), a DNA repair protein that removes alkyl groups located at the O6-positio...
Autores principales: | Yang, Zhikuan, Wei, Danping, Dai, Xiaoli, Stevens, Malcolm F. G., Bradshaw, Tracey D., Luo, Ying, Zhang, Jihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584802/ https://www.ncbi.nlm.nih.gov/pubmed/31263673 http://dx.doi.org/10.3389/fonc.2019.00485 |
Ejemplares similares
-
Antitumour imidazotetrazines: past, present… and future?
por: Stevens, Malcolm F. G., et al.
Publicado: (2023) -
The Medicinal Chemistry of Imidazotetrazine Prodrugs
por: Moody, Catherine L., et al.
Publicado: (2014) -
Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.
por: Goddard, C., et al.
Publicado: (1985) -
In search of effective therapies to overcome resistance to Temozolomide in brain tumours
por: Bouzinab, Kaouthar, et al.
Publicado: (2019) -
Tunable Stability of Imidazotetrazines Leads to a
Potent Compound for Glioblastoma
por: Svec, Riley L., et al.
Publicado: (2018)